去骨瓣减压术对重型动脉瘤性蛛网膜下腔出血患者功能结局与死亡的影响:系统综述与Meta分析
该系统综述与Meta分析纳入15项观察性队列研究共407例重型动脉瘤性蛛网膜下腔出血(aSAH)患者,评估去骨瓣减压术(DC)对功能结局与死亡的影响。汇总不良结局发生率为61.2%(95%CI 52%-69%),死亡率为27.8%(95%CI 21%-35%),中位随访12个月。原发性(早期)DC的不良结局发生率低于继发性(延迟)DC(47.5% vs 74.4%)。作者认为DC与高不良结局和死亡率相关,因多数研究缺乏稳健对照组,DC与其他干预相比对功能结局的影响仍未知,需要随机试验。
要点
- 汇总不良结局发生率为61.2%(95%CI 52%-69%),死亡率为27.8%(95%CI 21%-35%)。
- 原发性(早期)DC不良结局发生率47.5%(95%CI 31%-64%),低于继发性(延迟)DC的74.4%(95%CI 43%-91%)。
- 出院后1-3个月DC组死亡率有降低趋势(OR 0.58,95%CI 0.27-1.25;p=0.168),但1年随访未持续(OR 1.09,95%CI 0.55-2.13;p=0.79)。
核心结论
- DC与重型aSAH患者高不良结局发生率和死亡率相关。
- 因多数研究缺乏稳健对照组,DC与其他干预相比对功能结局的影响仍未知。
- 需要随机试验。
研究设计与样本
- 系统综述与Meta分析,遵循PRISMA指南,检索Ovid Medline、Embase、Web of Science和Cochrane Library数据库从建库至2015年10月。
- 仅纳入专门针对重型aSAH患者的研究。
- 共纳入15项研究407例患者,均为观察性队列。
- 采用随机效应模型计算事件率与比值比的汇总估计值及95%置信区间。
主要发现
- 所有研究中汇总不良结局发生率为61.2%(95%CI 52%-69%),死亡率为27.8%(95%CI 21%-35%),中位时间aSAH后12个月。
- 原发性(早期)DC的不良结局总事件率为47.5%(95%CI 31%-64%),继发性(延迟)DC为74.4%(95%CI 43%-91%)。
- 在有对照组的研究中,出院后1-3个月DC组死亡率有降低趋势(OR 0.58,95%CI 0.27-1.25;p=0.168),但1年随访时未持续(OR 1.09,95%CI 0.55-2.13;p=0.79)。
关键数值与推荐
- 重型aSAH定义为世界神经外科医师联盟(WFNS)分级IV级或V级。
- 良好结局定义为改良Rankin量表(mRS)评分1-3分、格拉斯哥结局量表(GOS)评分4-5分、扩展格拉斯哥结局量表(GOSE)评分5-8分。
- 不良结局定义为mRS评分4-6分、GOS评分1-3分、GOSE评分1-4分。
临床怎么用
- 原文未据此给出推荐。
局限性
- 多数研究缺乏稳健对照组。
- DC与其他干预相比对功能结局的影响仍未知。
- 需要随机试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE Patients with poor-grade aneurysmal subarachnoid hemorrhage (aSAH) (World Federation of Neurosurgical Societies Grade IV or V) are often considered for decompressive craniectomy (DC) as a rescue therapy for refractory intracranial hypertension. The authors performed a systematic review and meta-analysis to assess the impact of DC on functional outcome and death in patients after poor-grade aSAH. METHODS A systematic review and meta-analysis were performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Articles were identified through the Ovid Medline, Embase, Web of Science, and Cochrane Library databases from inception to October 2015. Only studies dedicated to patients with poor-grade aSAH were included. Primary outcomes were death and functional outcome assessed at any time period. Patients were grouped as having a favorable outcome (modified Rankin Scale [mRS] Scores 1-3, Glasgow Outcome Scale [GOS] Scores 4 and 5, extended Glasgow Outcome Scale [GOSE] Scores 5-8) or unfavorable outcome (mRS Scores 4-6, GOS Scores 1-3, GOSE Scores 1-4). Pooled estimates of event rates and odds ratios with 95% confidence intervals were calculated using the random-effects model. RESULTS Fifteen studies encompassing 407 patients were included in the meta-analysis (all observational cohorts). The pooled event rate for poor outcome across all studies was 61.2% (95% CI 52%-69%) and for death was 27.8% (95% CI 21%-35%) at a median of 12 months after aSAH. Primary (or early) DC resulted in a lower overall event rate for unfavorable outcome than secondary (or delayed) DC (47.5% [95% CI 31%-64%] vs 74.4% [95% CI 43%-91%], respectively). Among studies with comparison groups, there was a trend toward a reduced mortality rate 1–3 months after discharge among patients who underwent DC (OR 0.58 [95% CI 0.27–1.25]; p = 0.168). However, this trend was not sustained at the 1-year follow-up (OR 1.09 [95% CI 0.55-2.13]; p = 0.79). CONCLUSIONS Results of this study summarize the best evidence available in the literature for DC in patients with poor-grade aSAH. DC is associated with high rates of unfavorable outcome and death. Because of the lack of robust control groups in a majority of the studies, the effect of DC on functional outcomes versus that of other interventions for refractory intracranial hypertension is still unknown. A randomized trial is needed.
引用
- Alotaibi NM, Elkarim GA, Samuel N, et al. Effects of decompressive craniectomy on functional outcomes and death in poor-grade aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Neurosurg. 2017. PMID: 28059660. doi:10.3171/2016.9.JNS161383
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。